Literature DB >> 12228194

Endostatin: are the 2 years up yet?

Jan H M Schellens, Mark J Ratain.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12228194     DOI: 10.1200/JCO.2002.20.18.3758

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

Review 1.  Cardiovascular toxicities: clues to optimal administration of vascular endothelial growth factor signaling pathway inhibitors.

Authors:  Kelly L Snider; Michael L Maitland
Journal:  Target Oncol       Date:  2009-04-17       Impact factor: 4.493

Review 2.  Tumor reductive therapies and antitumor immunity.

Authors:  Huiqin Guo; Kangla Tsung
Journal:  Oncotarget       Date:  2017-06-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.